urea has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 3 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Guevara, B | 1 |
Cogdill, AG | 1 |
Garza-González, E | 1 |
Perez-Perez, GI | 1 |
Maldonado-Garza, HJ | 1 |
Bosques-Padilla, FJ | 1 |
Zucca, E | 1 |
Dreyling, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparison Between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Controlled Trial[NCT04039412] | Phase 4 | 330 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Questionnaire to measure the number of Participants with Treatment-Emergent Adverse Events (NCT04039412)
Timeframe: 10-14 days
Intervention | Participants (Count of Participants) |
---|---|
(1) Reverse Hybrid Regimen | 49 |
(2) Hybrid Regimen | 58 |
(3) Levofloxacin Quadruple Regimen | 44 |
Measuring the curative rate of each regimen by a fecal antigen test (NCT04039412)
Timeframe: 40-44 days
Intervention | Participants (Count of Participants) |
---|---|
(1) Reverse Hybrid Regimen | 102 |
(2) Hybrid Regimen | 101 |
(3) Levofloxacin Quadruple Regimen | 91 |
Questionnaire to evaluate the compliance with each treatment regimen (NCT04039412)
Timeframe: 10-14 days
Intervention | Participants (Count of Participants) |
---|---|
(1) Reverse Hybrid Regimen | 109 |
(2) Hybrid Regimen | 107 |
(3) Levofloxacin Quadruple Regimen | 108 |
2 reviews available for urea and Lymphoma of Mucosa-Associated Lymphoid Tissue
Article | Year |
---|---|
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath | 2020 |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
Topics: Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Helicobacte | 2014 |
1 other study available for urea and Lymphoma of Mucosa-Associated Lymphoid Tissue
Article | Year |
---|---|
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; beta 2-Microglobulin; Biomarkers; Biopsy; Breath Test | 2010 |